Ganesh Sambasivam

Ganesh Sambasivam

Active Director Whole-Time Director DIN 01469963
DIN 01469963 First appointment Aug 2006 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Aug 2006
Shareholding value •••• Premium profile

About Ganesh Sambasivam

Data last updated:

Ganesh Sambasivam has 20 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 4 companies, including Anthem Biosciences Limited and Neoanthem Lifesciences Private Limited. Formerly with 2 companies, such as Cellf Therapeutics Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹2,297 Cr; the largest is Anthem Biosciences Limited at ₹2,280 Cr (FY 2026).

DIN 01469963
Primary Designation Whole-Time Director
First Appointment 04 Aug 2006
Oldest Company Age 34 yrs
Largest company Anthem Biosciences Limited · ₹2,280 Cr (FY 2026)
Combined revenue ₹2,297 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anthem Biosciences Limited L24233KA2006PLC039703
Whole-Time Director04 Aug 20062006₹2,280 Cr (FY 2026)Active
Director22 Jul 20202020₹9.07 Cr (FY 2025)Active
Director07 Apr 20252016₹7.52 Cr (FY 2024)Active
Director07 Apr 20252018₹31.7 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cellf Therapeutics Private Limited U73100KA2020PTC134938
Director16 Jun 20202020₹6.1 Lakh (FY 2024)Active
Director09 Nov 20061991₹91.31 Cr (FY 2017)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Anthem Biosciences Limited
Neoanthem Lifesciences Private Limited
Aic Jyothy Institute Of Technology Foundation
Center For Incubation Innovation Research And Consultancy
Premium access

Shareholding and investment profile for Ganesh Sambasivam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesh Sambasivam

Ganesh Sambasivam has 20 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 4 companies, including Anthem Biosciences Limited and Neoanthem Lifesciences Private Limited. Formerly with 2 companies, such as Cellf Therapeutics Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹2,297 Cr; the largest is Anthem Biosciences Limited at ₹2,280 Cr (FY 2026).

Ganesh Sambasivam is associated with 4 companies as Whole-Time Director and Director, including Anthem Biosciences Limited (₹2,280 Cr), Neoanthem Lifesciences Private Limited (₹9.07 Cr), Center For Incubation Innovation Research And Consultancy (₹7.52 Cr).

Ganesh Sambasivam has expertise in General Business, Technology.

Ganesh Sambasivam has 20 years in corporate governance.

By reported revenue, the largest current company of Ganesh Sambasivam is Anthem Biosciences Limited, with revenue of ₹2,280 Cr (FY 2026).

The 4 current companies of Ganesh Sambasivam that report revenue have a combined latest revenue of ₹2,297 Cr.

Ganesh Sambasivam currently holds positions at 4 companies: Anthem Biosciences Limited (₹2,280 Cr), Neoanthem Lifesciences Private Limited (₹9.07 Cr), Center For Incubation Innovation Research And Consultancy (₹7.52 Cr), Aic Jyothy Institute Of Technology Foundation (₹31.7 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available